Clinical Trials Directory

Trials / Unknown

UnknownNCT02018614

International Validation Study Of The Algoplus Scale In Five Languages

INTERNATIONAL VALIDATION STUDY OF THE ALGOPLUS SCALE IN FIVE LANGUAGES

Status
Unknown
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
University Hospital, Clermont-Ferrand · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

Acute pain is responsible for unnecessary suffering. Among elderly patients, acute pain is frequent and underestimated, especially when these patients have cognitive disorders. The expression of pain is then modified and the conventional tools for evaluating pain cannot be used. Thus the existence of pain must be detected on the basis of a behavioural assessment. It is nonetheless necessary to have the assistance of standardised and validated tools. In France, the Doloplus Group has proposed a scale called Doloplus, validated in January 1999, and is now proposing a new scale for acute pain, Algoplus that has been validated in French (4). Doloplus has been recently translated and validated in 5 languages and an identical methodology will be used in this protocol. Internationally, although several teams are working on the development of scales that can be used for non-communicating elderly subjects, there is as yet no validated tool for acute pain assessment. Considering 1- the lack of tools at an international level and 2- the frequent request from many practitioners worldwide, the Doloplus group has offered to validate the Algoplus® scale in 5 foreign languages, English, German, Spanish, Italian, Portuguese. A rigorous methodology with the help of a statistician will be used in this validation process.

Detailed description

50 patients per language will be explored : t1 = time t Physician M Physician N t2 = time t+4 hours Physician M The methodology of the validation of our translation procedure consists of studying the reliability of the scale in two major steps: * Data from a sample of 50 patients will be used to explore the test-retest reliability of the scale administered by the same trained clinician, on two occasions four hours apart, without any treatment in between. The ALGOPLUS® scores obtained from the patients at a time t will be compared with their (t + 4 hours) scores to assess test-retest reliability. * For a sample of at least 50 patients, two physicians trained for the use of ALGOPLUS, will assess pain independently. A statistical test will be used to compare the results for the inter-rater reliability.

Conditions

Interventions

TypeNameDescription
OTHERalgoplus

Timeline

Start date
2014-01-01
Primary completion
2014-10-01
Completion
2015-01-01
First posted
2013-12-23
Last updated
2014-07-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02018614. Inclusion in this directory is not an endorsement.